BIOCRYST PHARMACEUTICALS INC — DEF 14A Filings
30 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by BIOCRYST PHARMACEUTICALS INC (BCRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOCRYST PHARMACEUTICALS INC has filed 30 DEF 14A documents with the SEC since 2015. To view all SEC filings by BIOCRYST PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001628280-25-019659 | Apr 24, 2025 | Jun 12, 2025 |
| DEF 14A | DEF 14A | 0001628280-24-018175 | Apr 25, 2024 | Jun 12, 2024 |
| DEF 14A | DEF 14A | 0001140361-23-020945 | Apr 27, 2023 | — |
| DEF 14A | DEF14A | 0001140361-22-015743 | Apr 25, 2022 | Jun 7, 2022 |
| DEF 14A | FORM DEF 14A | 0001171843-21-002454 | Apr 13, 2021 | May 25, 2021 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-20-002184 | Mar 31, 2020 | May 12, 2020 |
| DEF 14A | DEF 14A | 0001171843-19-002458 | Apr 17, 2019 | May 29, 2019 |
| DEF 14A | DEF 14A | 0001171843-18-006740 | Sep 28, 2018 | Oct 30, 2018 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-18-003822 | May 10, 2018 | Jun 20, 2018 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-17-002085 | Apr 12, 2017 | May 24, 2017 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-16-009092 | Apr 11, 2016 | May 23, 2016 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001171843-15-001911 | Apr 10, 2015 | May 20, 2015 |
| DEF 14A | DEF 14A | 0001193125-14-110222 | Mar 21, 2014 | May 2, 2014 |
| DEF 14A | DEF 14A | 0001193125-13-155396 | Apr 16, 2013 | May 31, 2013 |
| DEF 14A | NOTICE AND PROXY | 0001193125-12-154493 | Apr 9, 2012 | May 23, 2012 |
| DEF 14A | DEF 14A | 0000950123-11-032881 | Apr 5, 2011 | May 12, 2011 |
| DEF 14A | DEF 14A | 0000950123-10-032355 | Apr 6, 2010 | May 13, 2010 |
| DEF 14A | DEF 14A | 0000950144-09-002903 | Apr 3, 2009 | Apr 30, 2009 |
| DEF 14A | BIOCRYST PHARMACEUTICALS, INC. | 0000950144-08-002885 | Apr 16, 2008 | May 21, 2008 |
| DEF 14A | BIOCRYST PHARMACEUTICALS, INC. | 0000950144-07-003266 | Apr 10, 2007 | May 16, 2007 |
| DEF 14A | DEF 14A | 0001206774-06-000721 | Apr 10, 2006 | May 17, 2006 |
| DEF 14A | — | 0001206774-05-000539 | Apr 6, 2005 | May 11, 2005 |
| DEF 14A | — | 0001206774-04-000313 | Apr 12, 2004 | May 12, 2004 |
| DEF 14A | DEFINITIVE FORM OF NOTICE AND PROXY STATEMENT | 0001206774-03-000192 | Mar 27, 2003 | May 14, 2003 |
| DEF 14A | — | 0000891554-02-001567 | Mar 27, 2002 | May 15, 2002 |
| DEF 14A | PROXY STATEMENT | 0000891554-01-501923 | Apr 4, 2001 | May 17, 2001 |
| DEF 14A | DEF 14A | 0000912057-00-016432 | Apr 6, 2000 | May 17, 2000 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001005477-99-001625 | Apr 2, 1999 | May 12, 1999 |
| DEF 14A | SCHEDULE 14A | 0001005477-98-001195 | Apr 9, 1998 | May 20, 1998 |
| DEF 14A | DEFINITIVE 14A | 0000912057-97-012350 | Apr 9, 1997 | May 14, 1997 |